Orogen Therapeutics
PrivateLast Round
Seed
Jun 16, 2023
Total Funding Raised
$18.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Orogen Therapeutics is a biotechnology company that develops small-molecule therapies using a proprietary AI-enabled DNA-encoded library (DEL) platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orogen Therapeutics Comparables
Compare Orogen Therapeutics with similar companies based on industry and business-model similarity.
Orogen Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 16, 2023 |
Orogen Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Anterra Capital | Seed |
| Novalis LifeSciences | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 57% MoM.
- Feb 1, 2026
Monthly visitors grew 264% MoM, reaching 1.5K.
Orogen Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Orogen Therapeutics's valuation, stock price, and market status.